Stock Markets April 20, 2026 10:31 AM

Topbuild, Kaspi.kz and a Range of Small- to Mid-Cap Stocks Lead Monday’s Market Moves

Deal announcements, upgrades and corporate transactions drove pronounced gains and losses across large-, mid- and small-cap names

By Nina Shah BLD KSPI GFS OKTA MRVL
Topbuild, Kaspi.kz and a Range of Small- to Mid-Cap Stocks Lead Monday’s Market Moves
BLD KSPI GFS OKTA MRVL

Stocks across market-cap segments recorded sharp moves on Monday as deal headlines, analyst upgrades and corporate disclosures influenced share prices. Topbuild surged after a $17 billion acquisition announcement, Kaspi.kz climbed, and a mix of technology, biotech and special-purpose acquisition companies logged both meaningful gains and declines. Several small-cap issues posted double-digit increases while other names dropped following share offerings or shareholder sales.

Key Points

  • Deal announcements and corporate actions drove large percentage moves in both large- and mid-cap stocks, including a $17 billion acquisition involving Topbuild Corp (BLD) and a $3.1 billion transaction tied to USA Rare Earth and Serra Verde (USAR).
  • Analyst upgrades underpinned gains in identity security and semiconductor-related names, notably Okta Inc (OKTA) after a Barclays upgrade and Marvell Technology Group Ltd (MRVL) after a GF Securities upgrade.
  • Capital markets activity such as share offerings and planned shareholder sales were linked to steep declines in certain small-cap issues, including Sidus Space (SIDU) and Pono Capital Two (SBC).

Monday’s trading session produced a series of sizable swings across the market-cap spectrum. News items ranging from a takeover proposal to analyst upgrades and capital-market transactions were associated with notable percentage moves in individual stocks.


Large-cap movers

Among large-cap listings, Topbuild Corp (BLD) led the group with a significant advance after an announcement that QXO will acquire TopBuild in a stock-and-cash transaction valued at $17 billion - the stock rose 16.14% on the day. Kaspi.kz AO ADR (KSPI) added 11.11%. Semiconductor and security-related names also moved higher: Globalfoundries (GFS) gained 7.8%, Okta Inc (OKTA) climbed 4.8% following a Barclays upgrade citing demand in identity security, and Marvell Technology Group Ltd (MRVL) rose 3.92% after GF Securities upgraded the stock on expectations of data center growth. Other large-cap swings included Vector Acquisition (RKLB) up 5.4% and Atlassian Corp Plc (TEAM) up 5.01%.

On the downside in this bracket, Silversun Tech (QXO) declined 8.1%, Talen Energy Corp (TLN) fell 4.37%, and New Providence Acquisition Corp N (ASTS) dropped 8.17%.


Mid-cap activity

Mid-cap names experienced pronounced volatility. Nektar Therapeutics (NKTR) jumped 18.28% after reporting extended alopecia areata trial results at 52 weeks. MaxLinear Inc (MXL) rose 13.73%. Inflection Point Acquisition II (USAR) was up 14.04% in conjunction with news that USA Rare Earth will acquire Serra Verde for $3.1 billion in cash and stock. Oaktree Acquisition Corp (HIMS) climbed 8.85%, Legend Biotech Corp (LEGN) added 9.47%, and Hertz Global Holdings NAQ (HTZ) gained 4.71%.

Meanwhile, several mid-cap issues moved lower: Babcock & Wilcox Enterprises (BW) fell 3.81%, Agios Pharmaceuticals (AGIO) dropped 21.93%, and Fermi America LLC (FRMI) slid 18.93%.


Small-cap leaders and decliners

Smaller-cap stocks recorded some of the day’s largest percentage gains. Compass Pathways Plc (CMPS) surged 36.79%, ATAI Life Sciences BV (ATAI) gained 27.67%, Aevex Inc (AVEX) rose 25.97%, GH Research (GHRS) advanced 25.03%, and POET Tech NAQ (POET) climbed 23.55%. Additional small-cap winners included Sila Realty Trust (SILA) up 18.92%, GoGreen Investments (LZM) up 17.76%, and Candel Therapeutics (CADL) up 11.93%.

Notable declines among smaller issues included Sidus Space (SIDU), which dropped 19.99% after pricing a $58.5 million stock offering at $4.35 per share, and Pono Capital Two (SBC), which fell 17.59% as a shareholder announced an intention to sell 3.1 million SBC Medical shares at $3.25 each.


Overall, Monday’s session highlighted how corporate actions - acquisitions, analyst upgrades and capital raises or planned share sales - continued to be primary drivers of intraday performance across market-cap tiers.

Risks

  • Market reactions to deal announcements and analyst actions can produce heightened volatility across sectors, affecting technology, industrials and acquisitions-related stocks.
  • Share offerings and announced secondary sales can lead to sharp downward pressure on small-cap issuers, posing liquidity and price risk for investors in those companies.
  • Clinical-trial updates and other binary biotech news can generate large single-day moves for mid-cap pharmaceutical and biotech stocks.

More from Stock Markets

Wall Street Pauses as Oil Jumps to $95; Mega-Cap Tech Rally Takes a Breather Apr 20, 2026 Warsh to Sell Canadian Equity Holding If Confirmed, Amended Filing Shows Apr 20, 2026 AEX Edges Lower as Healthcare, Real Estate and Industrials Weigh on Amsterdam Close Apr 20, 2026 Milan Stocks Slip as Travel, Finance and Health Sectors Weigh on Index Apr 20, 2026 Hyundai Says Lost Middle East Sales Will Be Hard to Replace Quickly Apr 20, 2026